SLC6A3 and Parkinson disease: Firstly, taking into account of ethical and economic considerations, NM-MRI wasn’t compared with traditional imaging technologies of dopamine transporter SPECT or 123I-metaiodobenzylguanidine scintigraphy, which were supposed to reliable methods for diagnosis of PD (Jennings et al., 2004; Sawada et al., 2009).